News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Acambis PLC - Update On MVA Procurement
July 26, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Acambis plc ("Acambis") (LSE: ACM, NASDAQ: ACAM) provides an update on the US Government tender process relating to Modified Vaccinia Ankara ("MVA") attenuated smallpox vaccine.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
MORE ON THIS TOPIC
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
·
6 min read
·
Natalia Mesa
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
June 30, 2025
·
9 min read
·
Tristan Manalac
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
·
2 min read
·
Annalee Armstrong
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
·
2 min read
·
Jef Akst
